The Integration
Psychedelic Science 2025
Thank you for joining us at Psychedelic Science 2025: The Integration on June 16-20, 2025 in Denver, Colorado.
We are grateful to have welcomed a global community of thousands of attendees and more than 700 speakers as we come together to shape the future of mental health, medicine, and consciousness
The Most Extraordinary Week of the Psychedelic Movement.
.png)
Classes & Workshops
Dive deep into the world of psychedelic research, facilitated by experts in the fields of medicine, healthcare, commerce, policy, and culture.
Innovative Speakers
Featuring hundreds of leaders exploring the current and future state of psychedelics across 14 programming tracks.
10+ Educational Stages
Gain insights, and knowledge from hundreds of educational sessions featuring presenters from across the world.
Expo Hall
Be with your community in a city block-sized showcase of hundreds of psychedelic organizations, businesses, and projects.
14 Programming Tracks
Big ideas and high-profile speakers exploring the integration of psychedelics into broader society and culture.
Deep discussions for clinicians and facilitators from intake to integration, including critical viewpoints on evidence-based practices, education and training, ethics and accountability, and the delivery of care.
The world of ethnobotanical practices that use psychedelic plant medicines, including Indigenous, traditional, spiritual, and contemporary approaches.
New research spanning a variety of fields, including clinical trials, naturalistic use, risk & safety, public opinion, health and wellness, religion & spirituality, and global culture.
Findings and updates from clinical trials studying the potential of psychedelics in the treatment of serious mental illness and neurological disorders.
The latest insights on the neuroscience, pharmacology, and chemistry of psychedelics, and the quest to understand their mechanisms of action.
The legislative, judicial, and regulatory foundations required to create and manage safe and responsible access to psychedelics and a post-prohibition society.
A single-day forum focused on the new systems of state-regulated access to psychedelic experiences in Colorado and Oregon.
A single-day forum for veterans, first responders, and their families about the growing movement to bring psychedelic healing to their communities.
Personal selections from MAPS Founder Rick Doblin, focusing on the living legacy and pioneers of psychedelic research, therapy, and culture.
Dialogues and stories about psychedelics from the perspectives of unique and intersectional communities.
A half-day series on ways plant medicine can support Black communities in healing from systemic and interpersonal racism, trauma, and exploitation.
The intersection of psychedelics and society, including popular culture, the arts and music, media, religion and spirituality, ethnicity and culture, and the psychedelic community itself.
The infrastructure for scaling safe and responsible access to psychedelics, including finance, drug development, regulatory, clinics and service centers, technology, and community institutions.
.png)
Sutton
King
Co-Founder and Executive Director, Urban Indigenous Collective (UIC)
.png)
Leor
Roseman
Senior Lecturer and Psychedelic Researcher, University of Exeter
.png)
Hanifa Nayo
Washington
Co-Lead Investigator, Psychedelic Health Equity Initiative; Founding Team Member, Fireside Project
.png)
Alan
Davis
Associate Professor and Director, Center for Psychedelic Drug Research and Education at The Ohio State University
.png)
Pilar
Guzmán
Editorial Director, Oprah Daily
.png)
Tim
Ryan
Former United States Congressman, Ohio; President & CEO, Celtic Consulting
Bessel
Van der Kolk
Trauma Expert; Author of #1 NYT Bestseller “The Body Keeps the Score”
Kyrsten
Sinema
Former United States Senator, Arizona
Paul
Stamets
Earthling; Author; Mycologist; Founder, MycoMedica & Fungi Perfecti
.png)
Rick
Doblin
Founder & President, Multidisciplinary Association for Psychedelic Studies (MAPS)
Robin
Carhart-Harris
Neuroscience & Psychopharmacology Researcher, Carhart-Harris Lab at UCSF
.svg)
Monnica
Williams
Clinical Psychologist; Professor & Research Chair, University of Ottawa
Amy
Emerson
Former CEO of Lykos Therapeutics
Doug
Drysdale
CEO, Cybin
.png)
Taylor
West
Executive Director, Healing Advocacy Fund
.png)
Chris
Stauffer
Marcela
Ot'alora
Co-founder, Memoru Center for Visionary Healing Arts; Former Principal Investigator for Lykos MDMA-assisted therapy research
.svg)
David
Nutt
.png)
Amber
Capone
Co-founder and CEO, Veterans Exploring Treatment Solutions (VETS)
.png)
Diego
Ugalde
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
